0

524210

PNTKYOR

img img img img
No Data Available

PENTOKEY ORGANY (INDIA) LTD. Share Price Update

As of the latest trading session, PENTOKEY ORGANY (INDIA) LTD. share price is currently at ₹36.89, which is down by ₹-0.43 from its previous closing. Today, the stock has fluctuated between ₹36.30 and ₹36.89. Over the past year, PENTOKEY ORGANY (INDIA) LTD. has achieved a return of -6.55%. In the last month alone, the return has been -8.03%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PENTOKEY ORGANY (INDIA) LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    23.10

  • P/E Ratio (TTM)

    60.19

  • Beta

    0.34

  • Book Value / share

    16.29

  • Return on equity

    2.67%

  • EPS (TTM)

    0.62

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -0.29

info icon alternate text

PENTOKEY ORGANY (INDIA) LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue -2.09
Operating Expense -1.71
Net Profit -0.29
Net Profit Margin (%) 13.87
Earnings Per Share (EPS) -0.47
EBITDA -0.29
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.98
Operating Expense 0.95
Net Profit 0.14
Net Profit Margin (%) 14.28
Earnings Per Share (EPS) 0.23
EBITDA 0.14
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 5.06
Operating Expense 4.62
Net Profit 0.48
Net Profit Margin (%) 9.48
Earnings Per Share (EPS) 0.99
EBITDA 0.48
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.61
Operating Expense 0.63
Net Profit 0.06
Net Profit Margin (%) 9.83
Earnings Per Share (EPS) 0.09
EBITDA 0.06
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit 0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.06
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.83
Operating Expense 1.04
Net Profit 0.25
Net Profit Margin (%) 30.12
Earnings Per Share (EPS) 0.39
EBITDA 0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 4.40
Operating Expense 3.98
Net Profit 0.87
Net Profit Margin (%) 19.77
Earnings Per Share (EPS) 1.39
EBITDA 0.88
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 4.37
Operating Expense 3.55
Net Profit 3.18
Net Profit Margin (%) 72.76
Earnings Per Share (EPS) 5.06
EBITDA 3.21
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.42
Net Profit -0.16
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.26
EBITDA -0.16
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.54
Net Profit -0.24
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.38
EBITDA -0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.08
ROE % 2.67
ROCE % 2.67
Total Debt to Total Equity 0.00
EBITDA Margin 30.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 14.77
ROE % 9.98
ROCE % 10.09
Total Debt to Total Equity 0.00
EBITDA Margin 20.23
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.36
ROE % 46.83
ROCE % 47.28
Total Debt to Total Equity 0.00
EBITDA Margin 73.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.29
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.89
Total Assets 9.78
Total Liabilities 9.78
Total Equity 9.45
Share Outstanding 0
Price to Book Ratio 2.10
Return on Assets (%) 2.50
Return on Capital (%) 2.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.47
Total Assets 9.50
Total Liabilities 9.50
Total Equity 9.26
Share Outstanding 0
Price to Book Ratio 3.79
Return on Assets (%) 9.20
Return on Capital (%) 9.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.49
Total Assets 8.92
Total Liabilities 8.92
Total Equity 8.37
Share Outstanding 0
Price to Book Ratio 3.10
Return on Assets (%) 35.59
Return on Capital (%) 37.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.35
Total Assets 5.25
Total Liabilities 5.25
Total Equity 5.20
Share Outstanding 0
Price to Book Ratio 2.18
Return on Assets (%) -3.11
Return on Capital (%) -3.14
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.59
Total Assets 5.51
Total Liabilities 5.51
Total Equity 5.35
Share Outstanding 0
Price to Book Ratio 1.28
Return on Assets (%) -4.36
Return on Capital (%) -4.49
Particulars MAR 2025 (Values in Cr)
Net Income 0.24
Cash from Operations 0.25
Cash from Investing -0.20
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow 0.25
Particulars MAR 2024 (Values in Cr)
Net Income 0.87
Cash from Operations 0.55
Cash from Investing -0.58
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow 0.55
Particulars MAR 2023 (Values in Cr)
Net Income 3.17
Cash from Operations -0.10
Cash from Investing 0.18
Cash from Financing -0.02
Net change in Cash 0.06
Free Cash Flow -0.10
Particulars MAR 2022 (Values in Cr)
Net Income -0.16
Cash from Operations -0.39
Cash from Investing 0.22
Cash from Financing 0.00
Net change in Cash -0.19
Free Cash Flow -0.39
Particulars MAR 2021 (Values in Cr)
Net Income -0.24
Cash from Operations 0.53
Cash from Investing -0.55
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.10 11.30 1.35 200.01 23.12 / 43.30
BLISS GVS PHARMA LTD 225.00 21.51 2.10 2380.25 105.05 / 244.05
CIPLA LTD 1326.10 22.53 3.25 107119.80 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 335.15 11.15 2.52 986.38 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2637.35 44.42 26.16 44678.30 2220.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.10 25.10 3.63 200.01 23.12 / 43.30
AMRUTAJAN HEALTH LTD 602.95 30.15 5.09 1743.17 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8871.90 106.62 27.75 22179.75 6501.60 / 10653.05
BLISS GVS PHARMA LTD 225.00 30.65 2.15 2380.25 105.05 / 244.05

PENTOKEY ORGANY (INDIA) LTD. shareholding pattern

Holding

24.65%
73.03%
2.3%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

PENTOKEY ORGANY (INDIA) LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
36.89 -1.15 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 40.10
  • 26 Days 40.30
  • 10 Days 40.20
  • 50 Days 41.40
  • 12 Days 40.20
  • 100 Days 42.80
  • 20 Days 40.20
  • 200 Days 43.80
38.10 PIVOT

First Support

36.22

First Resistance

39.21

Second Support

35.11

Second Resistance

41.09

Third Support

33.23

Third Resistance

42.20

RSI

44.46

ADX

24.21

MACD

-0.11

Williams % R

-78.91

Commodity Channel Index (CCI)

-70.35

Date

2026-02-23

Week

845.00

Same Day

1177.00

Month

1491.00

1 Year

0.35

3 Year

0.55

Over 1 Month

-8.03%

down

Over 1 Year

-6.55%

down

Over 3 Months

-28.23%

down

Over 3 Years

19.17%

down

Over 6 Months

-16.43%

down

Over 5 Years

36.07%

down

PENTOKEY ORGANY (INDIA) LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
05 Aug 2013 1.0 Final 07 Aug 2013 Equity shares
09 Aug 2012 1.0 Final 11 Aug 2012 Equity shares
Ex-Date Ex-Bonus Ratio
14 Dec 2012 13 Dec 2012 2:3

Top Gainers

PENTOKEY ORGANY (INDIA) LTD. Share Price

Pentokey Organy (India) Ltd was incorporated on November 26, 1986. The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde. Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc.

In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices. Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde. As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low. Acetaldehyde was produced only to the extent of demand from customers. Further, Company could source Ethanol from various distilleries at competitive prices due to improved production of Sugar and Ethanol within the State of Maharashtra and so, it increased production capacity to 24000 TPA from 18000 TPA.

Parent organization Indian Private
NSE symbol [-]
Founded 1986
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Pentokey Organy (India) Ltd?

Answer Field

Pentokey Organy (India) Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 36.89 as on Feb 24 2026 01:43 PM.

What is the Market Cap of Pentokey Organy (India) Ltd Share?

Answer Field

The market cap of Pentokey Organy (India) Ltd for NSE ₹ 0.00 & for BSE ₹ 23.10 as on Feb 24 2026 01:43 PM.

What is the 52 Week High and Low of Pentokey Organy (India) Ltd?

Answer Field

The 52 Week High and Low of Pentokey Organy (India) Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 63.99 and ₹ 27.50.

What is 1 year return for Pentokey Organy (India) Ltd?

Answer Field

The 1 year returns on the stock has been -6.55%.

What is the P/E Ratio of Pentokey Organy (India) Ltd Share?

Answer Field

As on Feb 24 2026 01:43 PM the price-to-earnings (PE) ratio for Pentokey Organy (India) Ltd share is 60.19.

What is the PB ratio of Pentokey Organy (India) Ltd Share?

Answer Field

As on Feb 24 2026 01:43 PM, the price-to-book (PB) ratio for Pentokey Organy (India) Ltd share is 16.29.

How to Buy Pentokey Organy (India) Ltd Share?

Answer Field

You can trade in Pentokey Organy (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Pentokey Organy (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Pentokey Organy (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Pentokey Organy (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59